Estimation of clinical trial success rates and related parameters

Previous estimates of drug development success rates rely on relatively small samples from databases curated by the pharmaceutical industry and are subject to potential selection biases. Using a sample of 406 038 entries of clinical trial data for over 21 143 compounds from January 1, 2000 to Octobe...

Full description

Bibliographic Details
Main Authors: Wong, Chi Heem, Siah, Kien Wei, Lo, Andrew W
Other Authors: Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Format: Article
Published: Oxford University Press (OUP) 2020
Online Access:https://hdl.handle.net/1721.1/128480
_version_ 1811089059341139968
author Wong, Chi Heem
Siah, Kien Wei
Lo, Andrew W
author2 Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
author_facet Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Wong, Chi Heem
Siah, Kien Wei
Lo, Andrew W
author_sort Wong, Chi Heem
collection MIT
description Previous estimates of drug development success rates rely on relatively small samples from databases curated by the pharmaceutical industry and are subject to potential selection biases. Using a sample of 406 038 entries of clinical trial data for over 21 143 compounds from January 1, 2000 to October 31, 2015, we estimate aggregate clinical trial success rates and durations. We also compute disaggregated estimates across several trial features including disease type, clinical phase, industry or academic sponsor, biomarker presence, lead indication status, and time. In several cases, our results differ significantly in detail from widely cited statistics. For example, oncology has a 3.4% success rate in our sample vs. 5.1% in prior studies. However, after declining to 1.7% in 2012, this rate has improved to 2.5% and 8.3% in 2014 and 2015, respectively. In addition, trials that use biomarkers in patient-selection have higher overall success probabilities than trials without biomarkers.
first_indexed 2024-09-23T14:13:07Z
format Article
id mit-1721.1/128480
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T14:13:07Z
publishDate 2020
publisher Oxford University Press (OUP)
record_format dspace
spelling mit-1721.1/1284802022-10-01T19:51:02Z Estimation of clinical trial success rates and related parameters Wong, Chi Heem Siah, Kien Wei Lo, Andrew W Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science Sloan School of Management Previous estimates of drug development success rates rely on relatively small samples from databases curated by the pharmaceutical industry and are subject to potential selection biases. Using a sample of 406 038 entries of clinical trial data for over 21 143 compounds from January 1, 2000 to October 31, 2015, we estimate aggregate clinical trial success rates and durations. We also compute disaggregated estimates across several trial features including disease type, clinical phase, industry or academic sponsor, biomarker presence, lead indication status, and time. In several cases, our results differ significantly in detail from widely cited statistics. For example, oncology has a 3.4% success rate in our sample vs. 5.1% in prior studies. However, after declining to 1.7% in 2012, this rate has improved to 2.5% and 8.3% in 2014 and 2015, respectively. In addition, trials that use biomarkers in patient-selection have higher overall success probabilities than trials without biomarkers. 2020-11-13T21:39:39Z 2020-11-13T21:39:39Z 2018-01 2017-11 2019-02-22T16:30:21Z Article http://purl.org/eprint/type/JournalArticle 1465-4644 1468-4357 https://hdl.handle.net/1721.1/128480 Wong, Chi Heem et al. “Estimation of Clinical Trial Success Rates and Related Parameters.” Biostatistics 20, 2 (January 2018): 273–286 © 2018 Oxford University Press http://dx.doi.org/10.1093/BIOSTATISTICS/KXX069 Biostatistics Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Oxford University Press (OUP) Oxford University Press
spellingShingle Wong, Chi Heem
Siah, Kien Wei
Lo, Andrew W
Estimation of clinical trial success rates and related parameters
title Estimation of clinical trial success rates and related parameters
title_full Estimation of clinical trial success rates and related parameters
title_fullStr Estimation of clinical trial success rates and related parameters
title_full_unstemmed Estimation of clinical trial success rates and related parameters
title_short Estimation of clinical trial success rates and related parameters
title_sort estimation of clinical trial success rates and related parameters
url https://hdl.handle.net/1721.1/128480
work_keys_str_mv AT wongchiheem estimationofclinicaltrialsuccessratesandrelatedparameters
AT siahkienwei estimationofclinicaltrialsuccessratesandrelatedparameters
AT loandreww estimationofclinicaltrialsuccessratesandrelatedparameters